Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression (Q39503895)

12 September 2017

Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression (English)

1 reference

evasion of host immune response

12 September 2017

0 references

1 reference

1 reference

1 reference

2

1 reference

12 September 2017

8

Michael Weller

1 reference

12 September 2017

1

Michel Mittelbronn

1 reference

12 September 2017

9

Jörg Wischhusen

1 reference

12 September 2017

Pia Zeiner

3

1 reference

12 September 2017

Yvonne Dombrowski

4

1 reference

12 September 2017

Brigitte Frank

5

1 reference

12 September 2017

Cornelia Zachskorn

6

1 reference

12 September 2017

Patrick N Harter

7

1 reference

12 September 2017

21 July 2011

1 reference

12 September 2017

Acta Neuropathologica

1 reference

12 September 2017

122

1 reference

12 September 2017

3

1 reference

12 September 2017

353-365

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-011-0858-3

12 September 2017

0 references

cites work

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Cellular characterization of the peritumoral edema zone in malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF signal transduction initiated by binding to CD74

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Mechanisms and effectors of MIF-dependent promotion of tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Immunohistochemical localization of macrophage migration inhibitory factor (MIF) in tanycytes, subcommissural organ and choroid plexus in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

10.1007/S00401-011-0858-3

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference